JAMA Oncology: Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual Participant Data Packages
Dr. Ashley Hopkins (Flinders University) and colleagues, including Frank Rockhold [...]
Evidence Base: CRDSA FDA External Controls Roundtable Analysis and Recommendations
The Evidence Base, a news hub covering topics including real-world [...]
Pink Sheet Regulatory Analysis: CRDSA’s External Controls Roundtable
This Pink Sheet analysis (subscription needed): "US FDA’s External Controls [...]
Can Doctor AI predict cancer, save lives?
This Al Jazeera "Big Idea" feature highlights the AI data [...]
Assessing Innovation: How Pharma Makes Tech Investment Decisions
Read Bio-IT World's write-up of the plenary keynote panel that [...]
Establishing a Basis for Secondary Use Standards for Clinical Trials
Applied Clinical Trials Online has published CRDSA's paper "Establishing a [...]
Regulatory Focus Interview on CRDSA’s Supplemental Controls Demonstration Project
Regulatory Focus, a publication of Regulatory Affairs Professional Society (RAPS), [...]
Webinar Recording Now Available: “Mind the Data Sharing Gap: Navigating Sponsor Policies and Data Protection Methodologies”
The recording of the webinar, “A Review of BioPharma Sponsor [...]
Podcast: Unlocking the True Potential of Clinical Research Data
In Teckro's podcast episode "Unlocking the True Potential of Clinical [...]
CRDSA’s Data Protection Work Group whitepaper “A Review of BioPharma Sponsor Data Sharing Policies and Protection Methodologies” is now available
CRDSA’s Data Protection Work Group whitepaper “A Review of BioPharma [...]